Top Losers

Grana y Montero SAA (ADR) (NYSE: GRAM) shares dipped 28.6 percent to $2.37. Glancy Prongay & Murray LLP disclosed an investigation on behalf of Grana Y Montero investors. ITUS Corp (NASDAQ: ITUS) shares dropped 21.3 percent to $3.82. ITUS shares have climbed 106.90 percent over the...

Nordic American Offshore Ltd. (NYSE: NAO) shares declined 41.5 percent to $1.20. Nordic American Offshore priced its upsized offering of 40 million shares at $1.25 per share. FunctionX Inc (NASDAQ: FNCX) shares dropped 24.2 percent to $0.978. FunctionX priced its 4.5 million share offering...

Ocean Rig UDW Inc. (NASDAQ: ORIG) shares dipped 25.6 percent to $0.803 Ocean Rig UDW reported a Q4 loss of $3.71 billion on revenue of $355.4 million. Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) shares fell 22.6 percent to $4.19. Cyclacel reported that its Phase 3 SEAMLESS study did not...

Argos Therapeutics Inc (NASDAQ: ARGS) shares dipped 67.3 percent to $1.44 after the company disclosed that an independent data monitoring committee has recommended discontinuation of ADAPT Phase 3 trial of rocapuldencel-T in metastatic renal cell carcinoma. Servicesource International Inc (...

Rentech, Inc. (NASDAQ: RTK) shares declined 45.5 percent to $1.50 after the company disclosed that it has decided to idle its Wawa facility. Rentech is also exploring strategic alternatives for the firm. Cidara Therapeutics Inc (NASDAQ: CDTX) shares dropped 40.8 percent to $6.93 after the...

X T L Biopharmaceuticals Ltd (ADR) (NASDAQ: XTLB) shares tumbled 37.2 percent to $2.25 after the company reported a $2.5 million registered direct offering. ArQule, Inc. (NASDAQ: ARQL) shares declined 21.8 percent to $1.15. ArQule and Daiichi Sankyo disclosed that the METIV-HCC phase 3...

My Size, Inc. (NASDAQ: MYSZ) shares tumbled 39.3 percent to $3.89 after dropping 18.78 percent on Wednesday. ConforMIS Inc (NASDAQ: CFMS) shares dropped 31.8 percent to $5.83 after the company posted a wider-than-expected Q4 loss. Build-A-Bear Workshop, Inc (NYSE: BBW) shares dipped 29...

Sino-Global Shipping America, Ltd. (NASDAQ: SINO) shares declined 24.8 percent to $3.32. Sino-Global reported a $4.77 million registered direct offering. Galectin Therapeutics Inc (NASDAQ: GALT) shares dropped 22.2 percent to $1.40. Galectin Therapeutics shares have climbed 63.64 percent...

Aviragen Therapeutics Inc (NASDAQ: AVIR) shares dipped 36 percent to $0.672 after the company reported top-line results from its Phase 2b SPIRITUS trial of vapendavir. Ladenburg Thalmann downgraded Aviragen Therapeutics from Buy to Neutral. Gevo, Inc. (NASDAQ: GEVO) shares dipped 30 percent...

Vista Outdoor Inc (NYSE: VSTO) declined 21.1 percent to $20.31 after the company posted downbeat Q3 results and issued a weak FY17 forecast. Innovative Solutions & Support Inc (NASDAQ: ISSC) dropped 19.8 percent to $3.00. Innovative Solutions & Support reported a Q1 net loss of $1.2...

Galena Biopharma Inc (NASDAQ: GALE) shares dropped 39.8 percent to $0.843. Galena Biopharma priced its offering with anticipated gross proceeds of $17 million. Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) shares declined 28.6 percent to $0.928. Acura Pharmaceuticals shares have dropped 36.27...

FXCM Inc (NASDAQ: FXCM) shares dropped 43.4 percent to $3.88. Gain Capital Holdings Inc (NYSE: GCAP) agreed to acquire the client base of FXCM's U.S. operations after FXCM reported that it will be withdrawing from U.S. business. Giga-tronics, Incorporated (NASDAQ: GIGA) shares fell 18.6...

COMSCORE, Inc. (NASDAQ: SCOR) shares tumbled 22.4 percent to $25.19 after the company disclosed that it has notified the Nasdaq Hearings Panel that it will be unable to regain compliance with its SEC periodic reporting requirements by the deadline date. Aratana Therapeutics Inc (NASDAQ: PETX...

Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares dropped 25.2 percent to $3.23. Interpace Diagnostics priced 1.2 million shares at $3 per share. Benitec Biopharma Ltd (ADR) (NASDAQ: BNTC) shares fell 18.4 percent to $3.06 after jumping 134.38 percent on Thursday. Deckers Outdoor Corp...

Stemline Therapeutics Inc (NASDAQ: STML) shares tumbled 32.8 percent to $6.55. A cancer patient died from side effect in Stemline Therapeutics’ SL-401 drug trial, according to TheStreet.com's Adam Feuerstein. CSG Systems International, Inc. (NASDAQ: CSGS) fell 17.6 percent to $39....